Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Norio Seijiro Shirahama Insider Profile
4 Followers
Norio Seijiro Shirahama, President - Asia Pacific at Plus Therapeutics, holds 97.32K shares in Plus Therapeutics (Ticker: PSTV).
Norio Seijiro Shirahama has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Norio Seijiro Shirahama's holdings
Insider Roles
President - Asia Pacific
Roles that Norio Seijiro Shirahama holds in companies
Most Profitable Insider Trade
The most profitable trade made by Norio Seijiro Shirahama
Norio Seijiro Shirahama's Trading History
List of latest transactions for each holding click on a transaction to see Norio Seijiro Shirahama's performance on stock
You May Also Like
Norio Seijiro Shirahama insider profile FAQ
What is the percentage of profitable transactions made by Norio Seijiro Shirahama?
The percentage of profitable transactions made by Norio Seijiro Shirahama is ―.
What is the average return per transaction made by Norio Seijiro Shirahama?
The average return per transaction made by Norio Seijiro Shirahama is ―.
What stocks does Norio Seijiro Shirahama hold?
Norio Seijiro Shirahama holds: PSTV stocks.
What was Norio Seijiro Shirahama’s latest transaction?
Norio Seijiro Shirahama latest transaction was an Uninformative Sell of ―.
What was Norio Seijiro Shirahama's most profitable transaction?
Norio Seijiro Shirahama’s most profitable transaction was an Informative Buy of PSTV stock on June 7, 2010. The return on the trade was 23.90%.
What is Norio Seijiro Shirahama's role in Plus Therapeutics?
Norio Seijiro Shirahama's role in Plus Therapeutics is President - Asia Pacific.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.